Can reduction in hypertriglyceridaemia slow progression of microalbuminuria in patients with non-insulin-dependent diabetes mellitus?

European Journal of Clinical Investigation

Volumn 27, Issue 12, 1997, Pages 997-1002

  Smolders, Y M ^a   Van Eeden, A E ^b   Stehouwer, C D A ^a   Weijers, R N M ^a   Slaats, E H ^b   Silberbusch, J ^a  

^a ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Diabetic nephropathy; Hyperlipidaemia; Hypertriglyceridaemia; Microalbuminuria; Non insulin dependent diabetes mellitus

Indexed keywords

ALBUMIN; GEMFIBROZIL; PLACEBO;

ALBUMIN BLOOD LEVEL; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; HUMAN; HYPERTRIGLYCERIDEMIA; METABOLIC REGULATION; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0031437734     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1997.2330779.x     Document Type: Article

References (39)

1. Neu A, Hawkins M, Potok M, Thorogood M, Cohen D, Mann J. A prospective population based study of microalbuminuria as a predictor of mortality in N1DDM. Diab Care 1993;16:996-1003.
2. Mattock MB, Morrish NJ, Viberti G, Keen H, Fitzgerald AP, Jackson G. Prospective study of microalbuminuria as predictor of mortality in NIDDM. Diabetes 1992;41:736-41.
3. Fontbonne A, Eschwege E, Cambien F et al. Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Diabetologia 1989;32:300-4.
4. Dubois D, Chanson P, Timsit J et al. Remission of proteinuria following correction of hyperlipidaemia in NIDDM patients with nondiabetic glomerulopathy. Diab Care 1994; 17:906-8.
5. Niskanen L, Uusitupa M, Sarlund H et al. Microalbuminuria predicts the development of serum lipoprotein abnormalities favouring atherogenesis in newly diagnosed type 2 (non-insulindependent) diabetic patients. Diabetologia 1990;33:237-43.
6. Reverter JL, Senti M, Rubiés-Prat J et al. Relationship between lipoprotein profile and urinary albumin excretion in type II diabetic patients with stable metabolic control. Diab Care 1994; 17:189-94.
7. Ravid M, Neumann L, Lishner M. Plasma lipids and the progression of nephropathy in diabetes mellitus type II: effect of ACE inhibitors. Kidney Int 1995;47:907-10.
8. Standl E, Stiegler H. Microalbuminuria in a random cohort of recently diagnosed type 2 (non-insulin-dependent) diabetic patients living in the Greater Munich Area. Diabetologia 1993;36:1017-20.
9. Olivarius NdF, Andreasen AH, Keiding N, Mogensen CE. Epidemiology of renal involvement in newly diagnosed middle-aged and elderly diabetic patients. Cross-sectional data from the populationbased study: Diabetes Care in General Practice. Denmark. Diabetologia 1993:36:1007-16.
10. Coonrod BA, Ellis D, Becker DJ et al. Predictors of microalbuminuria in individuals with IDDM. Diab Care 1993:16:1376-83.
11. Metcalf P, Baker J, Scott A, Wild C, Scragg R, Dryson E. Albuminuria in people at least 40 years old: effect of obesity, hypertension, and hyperlipidaemia. Clin Chem 1992:38:1802-8.
12. Smulders YM, Rakic M, Stehouwer CD A, Weijcrs RNM, Slaats EH, Silberbusch J. Determinants of progression of microalbuminuria in patients with NIDDM. Diab Care 1997;20:999-1005.
13. Nielsen S, Schmilz O, Möller N et al. Renal function and insulin sensitivity during simvastatin treatment in type II (non-insulindependent) diabetic patients with microalbuminuria. Diabetologia 1993:36:1079-86.
14. Sasaki T, Kurata H, Nomura K, Utsunomiya K, Ikeda Y. Amelioration of proteinuria with pravastatin in hypercholesterolaemic patients with diabetes mellitus. Jpn J Med 1990;29:156-63.
15. Lam KSI, Cheng IKP, Janus ED, Pang RWC. Cholesterol lowering therapy may retard the progression of diabetic nephropathy. Diabetologia 1995:38:604-9.
16. Collins ACG, Sethi M, MacDonald FA, Viberti GC. Storage temperature and differing methods of sample preparation in the measurement of urinary albumin. Diabetologia 1993:36:993-7.
17. Siedel J, Hagele EO, Ziegenhorn J, Wahlefeld AW. Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency. Clin Chem 1983:29:1075-80.
18. Lopes-Virella MF, Stone P, Ellis S, Colwell JA. Cholesterol determination in high-density lipoproteins separated by three different methods. Clin Chem 1977;23:882-4.
19. McGowan MW, Artiss JD, Strandberg DR, Zak B. A peroxidasecoupled method for the determination of serum triglycérides. Clin Chem 1983:29:538-42.
20. Ravid M, Savin H, Jutrin I, Dental T, Katz B, Lishner M. Long term stabilizing effect of angiotensin converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients. Ann Intern Med 1993:118:577-81.
21. Grinsberg HN. Lipoprotein physiology in non-diabetic and diabetic states. Diab Care 199I;14:839-55.
22. Reaven GM. Insulin resistance, hyperinsulinemia, hypertriglyceridaemia and hypertension. Paralels between human disease and rodent models. Diab Care 1991;14:195-202.
23. Joles JA, Bijleveld C, Toi Av, Geelen MJH, Koomans HA. Plasma triglycéride levels are higher in nephrotic than in analbuminemic rats despite a similar increase in hepatic triglycéride secretion. Kidney Int 1995;47:566-72.
24. Wheeler DC, Bernard DB. Lipid abnormalities in the nephrotic syndrome: causes, consequences, and treatment. Am J Kidney Dis 1994:23:331-46.
25. Al-Shebeb, Fröhlich J, Magil AB. Glomerular disease in hypercholesterolemic guinea pigs: A pathogenetic study. Kidney Int I988;33:498-507.
26. Kasiske BL, O'Donnell M, Schmilz PG, Kirn Y, Keane WF. Renal injury of diet-induced hypercholesterolemia in rats. Kidney Int 1990;37:880-9I.
27. Smellie WSA, Warwick GL. Primary hyperlipidaemia is not associated with increased urinary albumin excretion. Nephrol Dial Transpl 1991;6:398-401.
28. Keane WF. Lipids and the kidney. Kidney Int 1994;46:910-20.
29. Wheeler DC. Lipids-What is the evidence for their role in progressive renal disease? Nephrol Dial Transplant 1995;10:14-16.
30. Hasslacher C, Bostedt-Kiesel A, Kempe HP, Wahl P. Effect of metabolic factors and blood pressure on kidney function in proteinuric type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1993;36:1051-56.
31. Krolewski AS, Warram JH, Christlieb AR. HypercholesterolemiaA determinant of renal function loss and deaths in IDDM patients with nephropathy. Kidney Int 1994;45:S125-S131.
32. Mulec H, Johnson SA, Bj0rck S. Relation between serum chlesterol and diabetic nephropathy (letter). Lancet 1990;335:1537-8.
33. Nielsen FS, Voldsgaard AI, Gal MA et al. Apolipoprotein(a) and cardiovascular disease in type 2 (non-insulin dependent) diabetic patients with and without diabetic nephropathy. Diabetologia 1993; 36:438-44.
34. Gilbert RE, Tsalamandris C, Bach LA et al. Long-term glycémie control and the rate of progression of early diabetic kidney disease. Kidney Int 1993;44:855-9.
35. Feldt-Rasmussen B, Mathiesen ER, Decken T. Effect of two years of strict metabolic control on progression of incipient nephropathy in insulin dependent diabetes. Lancet 1986;ii: 1300-4.
36. Gambardella S, Frontoni S, Lala A et al. Régression of microalbuminuria in type II diabetic, hypertensive patients after long term indapamide treatment. Am Heart J 1991;122:1232-8.
37. Stehouwer CDA, Nauta JJP, Zeldenrust GC, Hackeng WHL, Donker AJM, Ottolander GJHd. Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulindependent diabetes mellitus. Lancet 1992:340:319-23.
38. Stehouwer CDA, Fischer HRA, Kuijk AWRv, Polak BCP, Donker AJM. Endothelial dysfunction precedes the development of microalbuminuria in IDDM. Diabetes 1995;44:56I-4.
39. Phillipou G, Phillips PJ. Variability of urinary albumin excretion in patients with microalbuminuria. Diab Care 1994;17:425-27.